Healthcare Equipment and Supplies
Company Overview of Tenex Health, Inc.
Tenex Health, Inc. develops therapies for the treatment of tendon pain due to trauma or repetitive motion injuries. The company develops Tenex Health TX System, a surgical instrument that performs a percutaneous tenotomy and fasciotomy; and precisely cuts and removes disease and damaged tissue that leads to the restoration of natural tendon and soft-tissue function. It serves health care professionals. The company was founded in 2009 and is based in Lake Forest, California.
26902 Vista Terrace
Lake Forest, CA 92630
Founded in 2009
Key Executives for Tenex Health, Inc.
CEO, President & Director
Founder, Chief Scientific Officer and Director
Chief Financial Officer and Director
Chief Medical Officer, Member of Medical Advisory Board & Director
Compensation as of Fiscal Year 2017.
Tenex Health, Inc. Key Developments
Tenex Health, Inc. Announces Management Changes
Oct 18 17
Tenex Health, Inc. announced that its Board of Directors has appointed William ‘Bill’ Maya as the company’s President and Chief Executive Officer, effective October 9, 2017. Maya will replace Bernard Morrey, M.D., who will step down as interim Chief Executive Officer and resume his previously held role as Chief Medical Officer. The company also announced that Leslie ‘Les’ Cross has been appointed to its Board of Directors. Most recently Maya served as Chief Executive Officer at OrthAlign, Inc. Prior to OrthAlign Inc., Mr. Maya spent over twenty years serving as Chief Executive Officer at Vestara, LLC, DataLabs, Inc., Advanced Spine Fixation Systems, Inc., and Birtcher Medical Systems. Previously, Cross served as the Chairman of the Board of Directors of Alphatec Spine from 2011 to 2017. From 2012 to 2014 he also served as Alphatec Spine’s Chief Executive of Officer. Prior to 2011, Cross served as President and Chief Executive Officer of DJO Global, Inc.
Tenex Health, Inc. Presents at Canaccord Genuity2017 Musculoskeletal Conference, Mar-14-2017 10:00 AM
Mar 1 17
Tenex Health, Inc. Presents at Canaccord Genuity2017 Musculoskeletal Conference, Mar-14-2017 10:00 AM. Venue: Westin San Diego, San Diego, California, United States.
Tenex Health Inc. Obtains FDA 510K Clearance for New TX2 MicroTip
Mar 29 16
Tenex Health Inc. has obtained FDA 510K clearance for its new TX2 MicroTip. The TX2 MicroTip will primarily be utilized to address tendinosis of the shoulder and hip, two areas that were more difficult to reach using the original TX1 MicroTip due to its length. Tendinosis of the shoulder and hip affects approximately 5 million persons in the US alone every year. The company plans to make the TX2 MicroTip available in mid-2016 as a minimally invasive out-patient solution for patients who suffer from soft tissue pain. The TX2 MicroTip is a disposable surgical instrument that uses ultrasonic energy to specifically cut and remove targeted soft tissue. The extended length of the TX2 MicroTip, at 2 inches long, will allow physicians to complete a percutaneous tenotomy in regions of the body not typically accessible by the shorter TX1 instrument.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|